8-K 1 v67769e8-k.txt FORM 8-K 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DECEMBER 4, 2000 -------------------------------------------- (Date of Report) NEORX CORPORATION --------------------------------------------------------------------------- (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) WASHINGTON 0-14116 91-1261311 ---------------------------- --------------------- -------------------- (State or Other Jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.)
410 WEST HARRISON STREET, SEATTLE, WASHINGTON 98119-4007 ------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) (206) 281-7001 ------------------------------------------------------------------------------- (Registrant's telephone number, including area code) 2 ITEM 5. OTHER EVENTS The Company has updated its Skeletal Targeted Radiotherapy (STR) phase I/II data. See Exhibit 99.1 for additional information. ITEM 7. EXHIBITS 99.1 Press release dated December 4, 2000 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEORX CORPORATION Dated: December 5, 2000 By /s/ RICHARD L. ANDERSON ----------------------------------- Richard L. Anderson President and Chief Operating Officer -2- 4 EXHIBIT INDEX
Exhibit No. ----------- 99.1 Press Release dated December 4, 2000
-3-